VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Type 2 Diabetes Mellitus patients                  │ Type 2 Diabetes Mellitus patients                  │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patient who had been diagnosed within the previous │ Patient who had been diagnosed within the previous │     100 │
│ 12 months with HbA1c levels of 8.0-12.0%, did not  │ 12 months with HbA1c levels of 8.0-12.0%, did not  │         │
│ have a medical history related to diabetes, and    │ have a medical history related to diabetes, and    │         │
│ did not display proliferative retinopathy          │ did not display proliferative retinopathy          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ The use of weight-lowering drugs, any              │ The use of weight-lowering drugs, any              │     100 │
│ investigational blood-glucose or lipid-lowering    │ investigational blood-glucose or lipid-lowering    │         │
│ agent (other than statins or ezetimibe) within the │ agent (other than statins or ezetimibe) within the │         │
│ past 3 months                                      │ past 3 months                                      │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Previous treatment with systemic corticosteroids   │ Previous treatment with systemic corticosteroids   │     100 │
│ or a change in dosage of thyroid hormones in the   │ or a change in dosage of thyroid hormones in the   │         │
│ previous 6 weeks                                   │ previous 6 weeks                                   │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ The use of insulin within the 3 months prior to    │ The use of insulin within the 3 months prior to    │     100 │
│ screening                                          │ screening                                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Others                                             │ Others                                             │     100 │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤═════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                                   │   Score │
╞═══════════════════════════════════╪═════════════════════════════════════════════════╪═════════╡
│ Must have maximum age of 70 Years │ Type 2 Diabetes Mellitus patients               │      30 │
├───────────────────────────────────┼─────────────────────────────────────────────────┼─────────┤
│ Must have minimum age of 26 Years │ The use of insulin within the 3 months prior to │      31 │
│                                   │ screening                                       │         │
╘═══════════════════════════════════╧═════════════════════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 94
Average Levenshtein Ratio of individual lines: 82.625
OverAll Ratio: 88.3125
